tirzepatide fda approval 2022 The long awaited twincretin was just approved on Friday for type 2 diabetes! ๐ Marketed under the brand name Mounjaro, is the first dual GIP and GLP-1 receptor agonist. GIP First-in-Class Tirzepatide Wins FDA Approval
Pay in 4 interest-free payments of $6.93 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Aug 8 - Aug 13























![Plains (289) [Beta Edition] ARC031-C](https://cdn.shopify.com/s/files/1/0617/9821/9946/products/453feb6d-9ce6-5e56-9d51-0f8985bd266e_df248064-a073-4279-aa6b-21d7fb8cbe65.jpg?v=1658554869)


